Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Schenone

Showing results (121-130 of 173) with videos related to

Pageof 18
Sort By:
Pharmaceutics|February 25, 2023
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-<i>d</i>]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma MultiformeFederica Poggialini, Chiara Vagaggini, Annalaura Brai, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
AuNP Pyrazolo[3,4-<i>d</i>]pyrimidine Nanosystem in Combination with Radiotherapy against GlioblastomaAlessio Molinari, Giulia Iovenitti, Arianna Mancini, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2016
A cascade screening approach for the identification of Bcr-Abl myristate pocket binders active against wild type and T315I mutantMarco Radi, Ralf Schneider, Anna Lucia Fallacara, et al.
RSC Advances|July 9, 2024
Design, synthesis, and <i>in vitro</i> and <i>in silico</i> studies of morpholine derived thiazoles as bovine carbonic anhydrase-II inhibitorsMussarat Tasleem, Saeed Ullah, Ajmal Khan, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2018
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatmentAlessio Molinari, Anna Lucia Fallacara, Salvatore Di Maria, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2011
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cellsMarco Radi, Chiara Brullo, Emmanuele Crespan, et al.
Oncotarget|March 13, 2015
SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiationNadia Casini, Iris Maria Forte, Gianmarco Mastrogiovanni, et al.
European Journal of Medicinal Chemistry|August 25, 2018
Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interactionIlaria D'Agostino, Ilaria Giacchello, Giulio Nannetti, et al.
Bioorganic Chemistry|August 21, 2024
Synthesis, in vitro, and in silico study of novel pyridine based 1,3-diphenylurea derivatives as tyrosinase inhibitorsAnam Rubbab Pasha, Majid Khan, Ajmal Khan, et al.
Journal of Cellular Biochemistry|December 19, 2014
SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatmentElisa Ceccherini, Paola Indovina, Claudio Zamperini, et al.
Pageof 18

Showing results (121-130 of 173) with videos related to

Sort By:
Pageof 18
Pharmaceutics|February 25, 2023
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-<i>d</i>]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma MultiformeFederica Poggialini, Chiara Vagaggini, Annalaura Brai, et al.
ACS Medicinal Chemistry Letters|May 22, 2020
AuNP Pyrazolo[3,4-<i>d</i>]pyrimidine Nanosystem in Combination with Radiotherapy against GlioblastomaAlessio Molinari, Giulia Iovenitti, Arianna Mancini, et al.
Bioorganic & Medicinal Chemistry Letters|July 5, 2016
A cascade screening approach for the identification of Bcr-Abl myristate pocket binders active against wild type and T315I mutantMarco Radi, Ralf Schneider, Anna Lucia Fallacara, et al.
RSC Advances|July 9, 2024
Design, synthesis, and <i>in vitro</i> and <i>in silico</i> studies of morpholine derived thiazoles as bovine carbonic anhydrase-II inhibitorsMussarat Tasleem, Saeed Ullah, Ajmal Khan, et al.
Bioorganic & Medicinal Chemistry Letters|September 29, 2018
Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatmentAlessio Molinari, Anna Lucia Fallacara, Salvatore Di Maria, et al.
Bioorganic & Medicinal Chemistry Letters|August 23, 2011
Identification of potent c-Src inhibitors strongly affecting the proliferation of human neuroblastoma cellsMarco Radi, Chiara Brullo, Emmanuele Crespan, et al.
Oncotarget|March 13, 2015
SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiationNadia Casini, Iris Maria Forte, Gianmarco Mastrogiovanni, et al.
European Journal of Medicinal Chemistry|August 25, 2018
Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interactionIlaria D'Agostino, Ilaria Giacchello, Giulio Nannetti, et al.
Bioorganic Chemistry|August 21, 2024
Synthesis, in vitro, and in silico study of novel pyridine based 1,3-diphenylurea derivatives as tyrosinase inhibitorsAnam Rubbab Pasha, Majid Khan, Ajmal Khan, et al.
Journal of Cellular Biochemistry|December 19, 2014
SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatmentElisa Ceccherini, Paola Indovina, Claudio Zamperini, et al.
Pageof 18